CD8+ T lymphocytes identify and kill tumor cells playing a role in the anticancer immune response (50), and are usually supported by CD4+ T helper cells that release interferon-gamma (IFNγ) and interleukin-2 (IL-2) (51). The gene discussed is CD8A; the disease is neoplasm.